Global Biological Indicator Market
Global Biological Indicator Market

Biological Indicator Comprehensive Study by Type (Self-Contained Vials, Spore Strips, Spore Ampoules, Spore Suspension), Application (Steam Indicator, EO (Ethylene Oxide) Gas Indicator, Others), End User (Laboratories, Clinical Research Organizations, Academic Research Centers, Food and beverage industries, Pharmaceutical Manufacturing) Players and Region - Global Market Outlook to 2024

Biological Indicator Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Oct 2019 Edition 220 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Biological Indicator Market Overview:
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.

Market Drivers
  • Increasing Number of Surgical Procedures Globally
  • Growing Number of Hospitals & Increasing Investment in Healthcare Infrastructure


Restraints
  • Lack of Awareness on Sterilization Monitoring

Opportunities
  • The Growth of Pharmaceutical and Biotechnology Industry

Challenges
  • Dearth of Skilled Professionals


Competitive Landscape:

Some of the key players profiled in the report are 3M (United States), Steris Life Sciences (United States), NAMSA (United States), Mesa Laboratories Inc (United States), Terragene (Argentina), Advanced Sterilization Products (United States), SPSmedical (United States), BIoCI Systems, Inc. (United States), Cantel Medical Corporation (United States), Rubber Fab (United States), Getinge Group (Sweden), Propper Manufacturing Co. Inc. (United States), Astell (United Kingdom), Medline Industries (United States) and SIMICON GMBH (Germany). Considering Market by End User, the sub-segment i.e. Laboratories will boost the Biological Indicator market.

Market Highlights:

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Biological Indicator market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Biological Indicator market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Biological Indicator Manufacturers, Biological Indicator Service Providers, Pharmaceutical, Biotechnology, and Medical Device Companies, Hospitals and Clinical Laboratories, Academic and Research Institutes and Regulatory Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Self-Contained Vials
  • Spore Strips
  • Spore Ampoules
  • Spore Suspension
By Application
  • Steam Indicator
  • EO (Ethylene Oxide) Gas Indicator
  • Others
By End User
  • Laboratories
  • Clinical Research Organizations
  • Academic Research Centers
  • Food and beverage industries
  • Pharmaceutical Manufacturing

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Surgical Procedures Globally
      • 3.2.2. Growing Number of Hospitals & Increasing Investment in Healthcare Infrastructure
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Skilled Professionals
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biological Indicator, by Type, Application, End User and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Biological Indicator (Value)
      • 5.2.1. Global Biological Indicator by: Type (Value)
        • 5.2.1.1. Self-Contained Vials
        • 5.2.1.2. Spore Strips
        • 5.2.1.3. Spore Ampoules
        • 5.2.1.4. Spore Suspension
      • 5.2.2. Global Biological Indicator by: Application (Value)
        • 5.2.2.1. Steam Indicator
        • 5.2.2.2. EO (Ethylene Oxide) Gas Indicator
        • 5.2.2.3. Others
      • 5.2.3. Global Biological Indicator by: End User (Value)
        • 5.2.3.1. Laboratories
        • 5.2.3.2. Clinical Research Organizations
        • 5.2.3.3. Academic Research Centers
        • 5.2.3.4. Food and beverage industries
        • 5.2.3.5. Pharmaceutical Manufacturing
      • 5.2.4. Global Biological Indicator Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Biological Indicator: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Steris Life Sciences (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. NAMSA (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mesa Laboratories Inc (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Terragene (Argentina)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Advanced Sterilization Products (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. SPSmedical (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BIoCI Systems, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Cantel Medical Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Rubber Fab (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Getinge Group (Sweden)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Propper Manufacturing Co. Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Astell (United Kingdom)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Medline Industries (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. SIMICON GMBH (Germany)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global Biological Indicator Sale, by Type, Application, End User and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Biological Indicator (Value)
      • 7.2.1. Global Biological Indicator by: Type (Value)
        • 7.2.1.1. Self-Contained Vials
        • 7.2.1.2. Spore Strips
        • 7.2.1.3. Spore Ampoules
        • 7.2.1.4. Spore Suspension
      • 7.2.2. Global Biological Indicator by: Application (Value)
        • 7.2.2.1. Steam Indicator
        • 7.2.2.2. EO (Ethylene Oxide) Gas Indicator
        • 7.2.2.3. Others
      • 7.2.3. Global Biological Indicator by: End User (Value)
        • 7.2.3.1. Laboratories
        • 7.2.3.2. Clinical Research Organizations
        • 7.2.3.3. Academic Research Centers
        • 7.2.3.4. Food and beverage industries
        • 7.2.3.5. Pharmaceutical Manufacturing
      • 7.2.4. Global Biological Indicator Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biological Indicator: by Type(USD Million)
  • Table 2. Biological Indicator Self-Contained Vials , by Region USD Million (2013-2018)
  • Table 3. Biological Indicator Spore Strips , by Region USD Million (2013-2018)
  • Table 4. Biological Indicator Spore Ampoules , by Region USD Million (2013-2018)
  • Table 5. Biological Indicator Spore Suspension , by Region USD Million (2013-2018)
  • Table 6. Biological Indicator: by Application(USD Million)
  • Table 7. Biological Indicator Steam Indicator , by Region USD Million (2013-2018)
  • Table 8. Biological Indicator EO (Ethylene Oxide) Gas Indicator , by Region USD Million (2013-2018)
  • Table 9. Biological Indicator Others , by Region USD Million (2013-2018)
  • Table 10. Biological Indicator: by End User(USD Million)
  • Table 11. Biological Indicator Laboratories , by Region USD Million (2013-2018)
  • Table 12. Biological Indicator Clinical Research Organizations , by Region USD Million (2013-2018)
  • Table 13. Biological Indicator Academic Research Centers , by Region USD Million (2013-2018)
  • Table 14. Biological Indicator Food and beverage industries , by Region USD Million (2013-2018)
  • Table 15. Biological Indicator Pharmaceutical Manufacturing , by Region USD Million (2013-2018)
  • Table 16. South America Biological Indicator, by Country USD Million (2013-2018)
  • Table 17. South America Biological Indicator, by Type USD Million (2013-2018)
  • Table 18. South America Biological Indicator, by Application USD Million (2013-2018)
  • Table 19. South America Biological Indicator, by End User USD Million (2013-2018)
  • Table 20. Brazil Biological Indicator, by Type USD Million (2013-2018)
  • Table 21. Brazil Biological Indicator, by Application USD Million (2013-2018)
  • Table 22. Brazil Biological Indicator, by End User USD Million (2013-2018)
  • Table 23. Argentina Biological Indicator, by Type USD Million (2013-2018)
  • Table 24. Argentina Biological Indicator, by Application USD Million (2013-2018)
  • Table 25. Argentina Biological Indicator, by End User USD Million (2013-2018)
  • Table 26. Rest of South America Biological Indicator, by Type USD Million (2013-2018)
  • Table 27. Rest of South America Biological Indicator, by Application USD Million (2013-2018)
  • Table 28. Rest of South America Biological Indicator, by End User USD Million (2013-2018)
  • Table 29. Asia Pacific Biological Indicator, by Country USD Million (2013-2018)
  • Table 30. Asia Pacific Biological Indicator, by Type USD Million (2013-2018)
  • Table 31. Asia Pacific Biological Indicator, by Application USD Million (2013-2018)
  • Table 32. Asia Pacific Biological Indicator, by End User USD Million (2013-2018)
  • Table 33. China Biological Indicator, by Type USD Million (2013-2018)
  • Table 34. China Biological Indicator, by Application USD Million (2013-2018)
  • Table 35. China Biological Indicator, by End User USD Million (2013-2018)
  • Table 36. Japan Biological Indicator, by Type USD Million (2013-2018)
  • Table 37. Japan Biological Indicator, by Application USD Million (2013-2018)
  • Table 38. Japan Biological Indicator, by End User USD Million (2013-2018)
  • Table 39. India Biological Indicator, by Type USD Million (2013-2018)
  • Table 40. India Biological Indicator, by Application USD Million (2013-2018)
  • Table 41. India Biological Indicator, by End User USD Million (2013-2018)
  • Table 42. South Korea Biological Indicator, by Type USD Million (2013-2018)
  • Table 43. South Korea Biological Indicator, by Application USD Million (2013-2018)
  • Table 44. South Korea Biological Indicator, by End User USD Million (2013-2018)
  • Table 45. Taiwan Biological Indicator, by Type USD Million (2013-2018)
  • Table 46. Taiwan Biological Indicator, by Application USD Million (2013-2018)
  • Table 47. Taiwan Biological Indicator, by End User USD Million (2013-2018)
  • Table 48. Australia Biological Indicator, by Type USD Million (2013-2018)
  • Table 49. Australia Biological Indicator, by Application USD Million (2013-2018)
  • Table 50. Australia Biological Indicator, by End User USD Million (2013-2018)
  • Table 51. Rest of Asia-Pacific Biological Indicator, by Type USD Million (2013-2018)
  • Table 52. Rest of Asia-Pacific Biological Indicator, by Application USD Million (2013-2018)
  • Table 53. Rest of Asia-Pacific Biological Indicator, by End User USD Million (2013-2018)
  • Table 54. Europe Biological Indicator, by Country USD Million (2013-2018)
  • Table 55. Europe Biological Indicator, by Type USD Million (2013-2018)
  • Table 56. Europe Biological Indicator, by Application USD Million (2013-2018)
  • Table 57. Europe Biological Indicator, by End User USD Million (2013-2018)
  • Table 58. Germany Biological Indicator, by Type USD Million (2013-2018)
  • Table 59. Germany Biological Indicator, by Application USD Million (2013-2018)
  • Table 60. Germany Biological Indicator, by End User USD Million (2013-2018)
  • Table 61. France Biological Indicator, by Type USD Million (2013-2018)
  • Table 62. France Biological Indicator, by Application USD Million (2013-2018)
  • Table 63. France Biological Indicator, by End User USD Million (2013-2018)
  • Table 64. Italy Biological Indicator, by Type USD Million (2013-2018)
  • Table 65. Italy Biological Indicator, by Application USD Million (2013-2018)
  • Table 66. Italy Biological Indicator, by End User USD Million (2013-2018)
  • Table 67. United Kingdom Biological Indicator, by Type USD Million (2013-2018)
  • Table 68. United Kingdom Biological Indicator, by Application USD Million (2013-2018)
  • Table 69. United Kingdom Biological Indicator, by End User USD Million (2013-2018)
  • Table 70. Netherlands Biological Indicator, by Type USD Million (2013-2018)
  • Table 71. Netherlands Biological Indicator, by Application USD Million (2013-2018)
  • Table 72. Netherlands Biological Indicator, by End User USD Million (2013-2018)
  • Table 73. Rest of Europe Biological Indicator, by Type USD Million (2013-2018)
  • Table 74. Rest of Europe Biological Indicator, by Application USD Million (2013-2018)
  • Table 75. Rest of Europe Biological Indicator, by End User USD Million (2013-2018)
  • Table 76. MEA Biological Indicator, by Country USD Million (2013-2018)
  • Table 77. MEA Biological Indicator, by Type USD Million (2013-2018)
  • Table 78. MEA Biological Indicator, by Application USD Million (2013-2018)
  • Table 79. MEA Biological Indicator, by End User USD Million (2013-2018)
  • Table 80. Middle East Biological Indicator, by Type USD Million (2013-2018)
  • Table 81. Middle East Biological Indicator, by Application USD Million (2013-2018)
  • Table 82. Middle East Biological Indicator, by End User USD Million (2013-2018)
  • Table 83. Africa Biological Indicator, by Type USD Million (2013-2018)
  • Table 84. Africa Biological Indicator, by Application USD Million (2013-2018)
  • Table 85. Africa Biological Indicator, by End User USD Million (2013-2018)
  • Table 86. North America Biological Indicator, by Country USD Million (2013-2018)
  • Table 87. North America Biological Indicator, by Type USD Million (2013-2018)
  • Table 88. North America Biological Indicator, by Application USD Million (2013-2018)
  • Table 89. North America Biological Indicator, by End User USD Million (2013-2018)
  • Table 90. United States Biological Indicator, by Type USD Million (2013-2018)
  • Table 91. United States Biological Indicator, by Application USD Million (2013-2018)
  • Table 92. United States Biological Indicator, by End User USD Million (2013-2018)
  • Table 93. Canada Biological Indicator, by Type USD Million (2013-2018)
  • Table 94. Canada Biological Indicator, by Application USD Million (2013-2018)
  • Table 95. Canada Biological Indicator, by End User USD Million (2013-2018)
  • Table 96. Mexico Biological Indicator, by Type USD Million (2013-2018)
  • Table 97. Mexico Biological Indicator, by Application USD Million (2013-2018)
  • Table 98. Mexico Biological Indicator, by End User USD Million (2013-2018)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Biological Indicator: by Type(USD Million)
  • Table 115. Biological Indicator Self-Contained Vials , by Region USD Million (2019-2024)
  • Table 116. Biological Indicator Spore Strips , by Region USD Million (2019-2024)
  • Table 117. Biological Indicator Spore Ampoules , by Region USD Million (2019-2024)
  • Table 118. Biological Indicator Spore Suspension , by Region USD Million (2019-2024)
  • Table 119. Biological Indicator: by Application(USD Million)
  • Table 120. Biological Indicator Steam Indicator , by Region USD Million (2019-2024)
  • Table 121. Biological Indicator EO (Ethylene Oxide) Gas Indicator , by Region USD Million (2019-2024)
  • Table 122. Biological Indicator Others , by Region USD Million (2019-2024)
  • Table 123. Biological Indicator: by End User(USD Million)
  • Table 124. Biological Indicator Laboratories , by Region USD Million (2019-2024)
  • Table 125. Biological Indicator Clinical Research Organizations , by Region USD Million (2019-2024)
  • Table 126. Biological Indicator Academic Research Centers , by Region USD Million (2019-2024)
  • Table 127. Biological Indicator Food and beverage industries , by Region USD Million (2019-2024)
  • Table 128. Biological Indicator Pharmaceutical Manufacturing , by Region USD Million (2019-2024)
  • Table 129. South America Biological Indicator, by Country USD Million (2019-2024)
  • Table 130. South America Biological Indicator, by Type USD Million (2019-2024)
  • Table 131. South America Biological Indicator, by Application USD Million (2019-2024)
  • Table 132. South America Biological Indicator, by End User USD Million (2019-2024)
  • Table 133. Brazil Biological Indicator, by Type USD Million (2019-2024)
  • Table 134. Brazil Biological Indicator, by Application USD Million (2019-2024)
  • Table 135. Brazil Biological Indicator, by End User USD Million (2019-2024)
  • Table 136. Argentina Biological Indicator, by Type USD Million (2019-2024)
  • Table 137. Argentina Biological Indicator, by Application USD Million (2019-2024)
  • Table 138. Argentina Biological Indicator, by End User USD Million (2019-2024)
  • Table 139. Rest of South America Biological Indicator, by Type USD Million (2019-2024)
  • Table 140. Rest of South America Biological Indicator, by Application USD Million (2019-2024)
  • Table 141. Rest of South America Biological Indicator, by End User USD Million (2019-2024)
  • Table 142. Asia Pacific Biological Indicator, by Country USD Million (2019-2024)
  • Table 143. Asia Pacific Biological Indicator, by Type USD Million (2019-2024)
  • Table 144. Asia Pacific Biological Indicator, by Application USD Million (2019-2024)
  • Table 145. Asia Pacific Biological Indicator, by End User USD Million (2019-2024)
  • Table 146. China Biological Indicator, by Type USD Million (2019-2024)
  • Table 147. China Biological Indicator, by Application USD Million (2019-2024)
  • Table 148. China Biological Indicator, by End User USD Million (2019-2024)
  • Table 149. Japan Biological Indicator, by Type USD Million (2019-2024)
  • Table 150. Japan Biological Indicator, by Application USD Million (2019-2024)
  • Table 151. Japan Biological Indicator, by End User USD Million (2019-2024)
  • Table 152. India Biological Indicator, by Type USD Million (2019-2024)
  • Table 153. India Biological Indicator, by Application USD Million (2019-2024)
  • Table 154. India Biological Indicator, by End User USD Million (2019-2024)
  • Table 155. South Korea Biological Indicator, by Type USD Million (2019-2024)
  • Table 156. South Korea Biological Indicator, by Application USD Million (2019-2024)
  • Table 157. South Korea Biological Indicator, by End User USD Million (2019-2024)
  • Table 158. Taiwan Biological Indicator, by Type USD Million (2019-2024)
  • Table 159. Taiwan Biological Indicator, by Application USD Million (2019-2024)
  • Table 160. Taiwan Biological Indicator, by End User USD Million (2019-2024)
  • Table 161. Australia Biological Indicator, by Type USD Million (2019-2024)
  • Table 162. Australia Biological Indicator, by Application USD Million (2019-2024)
  • Table 163. Australia Biological Indicator, by End User USD Million (2019-2024)
  • Table 164. Rest of Asia-Pacific Biological Indicator, by Type USD Million (2019-2024)
  • Table 165. Rest of Asia-Pacific Biological Indicator, by Application USD Million (2019-2024)
  • Table 166. Rest of Asia-Pacific Biological Indicator, by End User USD Million (2019-2024)
  • Table 167. Europe Biological Indicator, by Country USD Million (2019-2024)
  • Table 168. Europe Biological Indicator, by Type USD Million (2019-2024)
  • Table 169. Europe Biological Indicator, by Application USD Million (2019-2024)
  • Table 170. Europe Biological Indicator, by End User USD Million (2019-2024)
  • Table 171. Germany Biological Indicator, by Type USD Million (2019-2024)
  • Table 172. Germany Biological Indicator, by Application USD Million (2019-2024)
  • Table 173. Germany Biological Indicator, by End User USD Million (2019-2024)
  • Table 174. France Biological Indicator, by Type USD Million (2019-2024)
  • Table 175. France Biological Indicator, by Application USD Million (2019-2024)
  • Table 176. France Biological Indicator, by End User USD Million (2019-2024)
  • Table 177. Italy Biological Indicator, by Type USD Million (2019-2024)
  • Table 178. Italy Biological Indicator, by Application USD Million (2019-2024)
  • Table 179. Italy Biological Indicator, by End User USD Million (2019-2024)
  • Table 180. United Kingdom Biological Indicator, by Type USD Million (2019-2024)
  • Table 181. United Kingdom Biological Indicator, by Application USD Million (2019-2024)
  • Table 182. United Kingdom Biological Indicator, by End User USD Million (2019-2024)
  • Table 183. Netherlands Biological Indicator, by Type USD Million (2019-2024)
  • Table 184. Netherlands Biological Indicator, by Application USD Million (2019-2024)
  • Table 185. Netherlands Biological Indicator, by End User USD Million (2019-2024)
  • Table 186. Rest of Europe Biological Indicator, by Type USD Million (2019-2024)
  • Table 187. Rest of Europe Biological Indicator, by Application USD Million (2019-2024)
  • Table 188. Rest of Europe Biological Indicator, by End User USD Million (2019-2024)
  • Table 189. MEA Biological Indicator, by Country USD Million (2019-2024)
  • Table 190. MEA Biological Indicator, by Type USD Million (2019-2024)
  • Table 191. MEA Biological Indicator, by Application USD Million (2019-2024)
  • Table 192. MEA Biological Indicator, by End User USD Million (2019-2024)
  • Table 193. Middle East Biological Indicator, by Type USD Million (2019-2024)
  • Table 194. Middle East Biological Indicator, by Application USD Million (2019-2024)
  • Table 195. Middle East Biological Indicator, by End User USD Million (2019-2024)
  • Table 196. Africa Biological Indicator, by Type USD Million (2019-2024)
  • Table 197. Africa Biological Indicator, by Application USD Million (2019-2024)
  • Table 198. Africa Biological Indicator, by End User USD Million (2019-2024)
  • Table 199. North America Biological Indicator, by Country USD Million (2019-2024)
  • Table 200. North America Biological Indicator, by Type USD Million (2019-2024)
  • Table 201. North America Biological Indicator, by Application USD Million (2019-2024)
  • Table 202. North America Biological Indicator, by End User USD Million (2019-2024)
  • Table 203. United States Biological Indicator, by Type USD Million (2019-2024)
  • Table 204. United States Biological Indicator, by Application USD Million (2019-2024)
  • Table 205. United States Biological Indicator, by End User USD Million (2019-2024)
  • Table 206. Canada Biological Indicator, by Type USD Million (2019-2024)
  • Table 207. Canada Biological Indicator, by Application USD Million (2019-2024)
  • Table 208. Canada Biological Indicator, by End User USD Million (2019-2024)
  • Table 209. Mexico Biological Indicator, by Type USD Million (2019-2024)
  • Table 210. Mexico Biological Indicator, by Application USD Million (2019-2024)
  • Table 211. Mexico Biological Indicator, by End User USD Million (2019-2024)
  • Table 212. Research Programs/Design for This Report
  • Table 213. Key Data Information from Secondary Sources
  • Table 214. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biological Indicator: by Type USD Million (2013-2018)
  • Figure 5. Global Biological Indicator: by Application USD Million (2013-2018)
  • Figure 6. Global Biological Indicator: by End User USD Million (2013-2018)
  • Figure 7. South America Biological Indicator Share (%), by Country
  • Figure 8. Asia Pacific Biological Indicator Share (%), by Country
  • Figure 9. Europe Biological Indicator Share (%), by Country
  • Figure 10. MEA Biological Indicator Share (%), by Country
  • Figure 11. North America Biological Indicator Share (%), by Country
  • Figure 12. Global Biological Indicator share by Players 2018 (%)
  • Figure 13. Global Biological Indicator share by Players (Top 3) 2018(%)
  • Figure 14. Global Biological Indicator share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 17. 3M (United States) Revenue: by Geography 2018
  • Figure 18. Steris Life Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 19. Steris Life Sciences (United States) Revenue: by Geography 2018
  • Figure 20. NAMSA (United States) Revenue, Net Income and Gross profit
  • Figure 21. NAMSA (United States) Revenue: by Geography 2018
  • Figure 22. Mesa Laboratories Inc (United States) Revenue, Net Income and Gross profit
  • Figure 23. Mesa Laboratories Inc (United States) Revenue: by Geography 2018
  • Figure 24. Terragene (Argentina) Revenue, Net Income and Gross profit
  • Figure 25. Terragene (Argentina) Revenue: by Geography 2018
  • Figure 26. Advanced Sterilization Products (United States) Revenue, Net Income and Gross profit
  • Figure 27. Advanced Sterilization Products (United States) Revenue: by Geography 2018
  • Figure 28. SPSmedical (United States) Revenue, Net Income and Gross profit
  • Figure 29. SPSmedical (United States) Revenue: by Geography 2018
  • Figure 30. BIoCI Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. BIoCI Systems, Inc. (United States) Revenue: by Geography 2018
  • Figure 32. Cantel Medical Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Cantel Medical Corporation (United States) Revenue: by Geography 2018
  • Figure 34. Rubber Fab (United States) Revenue, Net Income and Gross profit
  • Figure 35. Rubber Fab (United States) Revenue: by Geography 2018
  • Figure 36. Getinge Group (Sweden) Revenue, Net Income and Gross profit
  • Figure 37. Getinge Group (Sweden) Revenue: by Geography 2018
  • Figure 38. Propper Manufacturing Co. Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Propper Manufacturing Co. Inc. (United States) Revenue: by Geography 2018
  • Figure 40. Astell (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 41. Astell (United Kingdom) Revenue: by Geography 2018
  • Figure 42. Medline Industries (United States) Revenue, Net Income and Gross profit
  • Figure 43. Medline Industries (United States) Revenue: by Geography 2018
  • Figure 44. SIMICON GMBH (Germany) Revenue, Net Income and Gross profit
  • Figure 45. SIMICON GMBH (Germany) Revenue: by Geography 2018
  • Figure 46. Global Biological Indicator: by Type USD Million (2019-2024)
  • Figure 47. Global Biological Indicator: by Application USD Million (2019-2024)
  • Figure 48. Global Biological Indicator: by End User USD Million (2019-2024)
  • Figure 49. South America Biological Indicator Share (%), by Country
  • Figure 50. Asia Pacific Biological Indicator Share (%), by Country
  • Figure 51. Europe Biological Indicator Share (%), by Country
  • Figure 52. MEA Biological Indicator Share (%), by Country
  • Figure 53. North America Biological Indicator Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • 3M (United States)
  • Steris Life Sciences (United States)
  • NAMSA (United States)
  • Mesa Laboratories Inc (United States)
  • Terragene (Argentina)
  • Advanced Sterilization Products (United States)
  • SPSmedical (United States)
  • BIoCI Systems, Inc. (United States)
  • Cantel Medical Corporation (United States)
  • Rubber Fab (United States)
  • Getinge Group (Sweden)
  • Propper Manufacturing Co. Inc. (United States)
  • Astell (United Kingdom)
  • Medline Industries (United States)
  • SIMICON GMBH (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation